10X Genomics Inc
NASDAQ:TXG

Watchlist Manager
10X Genomics Inc Logo
10X Genomics Inc
NASDAQ:TXG
Watchlist
Price: 18.32 USD 10.23% Market Closed
Market Cap: 2.3B USD

During the last 3 months 10X Genomics Inc insiders have not bought any shares, and sold 635.2k USD worth of shares. The stock price has increased by 45% over this period (open performance analysis).

The last transaction was made on Nov 24, 2025 by Taich Adam , who sold 225.9k USD worth of TXG shares.

Last Transactions:
Taich Adam
$-225.9k
Hindson Benjamin J.
$-157.4k
Saxonov Serge
$-251.9k
Saxonov Serge
$-128.9k
Taich Adam
$-307.7k
Hindson Benjamin J.
$-103.2k
Hindson Benjamin J.
$-62.1k
Saxonov Serge
$-77.5k
Taich Adam
$-33.6k
Saxonov Serge
$-84.4k
Hindson Benjamin J.
$-50.6k
Saxonov Serge
$-56.3k
Mateo Alan
$+445.6k
Hindson Benjamin J.
$-79.5k
Saxonov Serge
$-91.6k
Saxonov Serge
$-152.1k
Hindson Benjamin J.
$-98k
Mcanear Justin J.
$-66.7k
Hindson Benjamin J.
$-99.3k
Mcanear Justin J.
$-71.4k
Saxonov Serge
$-118.5k
Saxonov Serge
$-205k
Mcanear Justin J.
$-86.4k
Hindson Benjamin J.
$-121.1k
Saxonov Serge
$-130.7k
Saxonov Serge
$-160.3k
Saxonov Serge
$-49.5k
Saxonov Serge
$-133.7k
Saxonov Serge
$-16.3k
Saxonov Serge
$-162.8k
Hindson Benjamin J.
$-149.5k
Mcanear Justin J.
$-72.8k
View All Transactions

During the last 3 months 10X Genomics Inc insiders have not bought any shares, and sold 635.2k USD worth of shares. The stock price has increased by 45% over this period (open performance analysis).

The last transaction was made on Nov 24, 2025 by Taich Adam , who sold 225.9k USD worth of TXG shares.

Sold
0-3
months
635.2k USD
3
3-6
months
539.7k USD
3
6-9
months
173.2k USD
3
9-12
months
191.3k USD
2
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
1
445.6k USD

10X Genomics Inc
Insider Trading Chart

10X Genomics Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

10X Genomics Inc
Last Insider Transactions

Global
Insiders Monitor

10X Genomics Inc
Glance View

10X Genomics Inc. stands as a beacon of innovation in the rapidly evolving field of genomics, where the frontier of scientific discovery meets commercial enterprise. Founded in 2012, the company emerged from a vision to delve deeper into the cellular universe, offering tools that illuminate the complexities of biological systems. Nestled in the heart of Silicon Valley, the company has harnessed cutting-edge technology to develop platforms that enable scientists to observe cellular behavior with unprecedented clarity and detail. These tools are particularly vital for understanding the nuances of diseases and developing more targeted therapeutic interventions. At its core, 10X Genomics specializes in creating sophisticated single-cell and spatial analysis solutions, which allow researchers to dissect the minutiae of genetic information within individual cells—an advancement that traditional bulk sequencing techniques simply cannot achieve. This innovative approach is not just a scientific marvel but a robust business model that thrives on the burgeoning demand for advanced genomic research. 10X Genomics generates revenue through a blend of product sales and services. Its primary offerings include instruments and proprietary consumables, such as reagent kits that are fundamental to extracting actionable insights from genomic data. The company’s unique Chromium and Visium platforms are sought after by academic institutions, pharmaceutical companies, and clinical research organizations worldwide. By coupling high-margin consumables with sophisticated hardware, 10X Genomics ensures a recurring revenue stream that supports sustained growth. Meanwhile, it continues to invest heavily in research and development, ensuring its place at the cutting edge of genomic science and maintaining a competitive advantage in a space that demands relentless innovation.

TXG Intrinsic Value
21.27 USD
Undervaluation 14%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top